MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
5082.37%
Quick Ratio
5082.37%
Cash Ratio
1702.34%
Debt to Asset Ratio
4.60%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating leaseright-of-useasset...
    • Others
Liabilities Breakdown
    • Additionalpaid-incapital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
345,558
157,828
112,279
58,338
Marketable securities
668,432
222,011
230,859
94,473
Restricted cash
0
0
428
428
Prepaid expenses and other current assets
17,681
12,488
10,190
10,540
Total current assets
1,031,671
392,327
353,756
163,779
Property, plant and equipment, gross
17,379
17,322
17,406
17,406
Less accumulated depreciation
11,285
10,941
10,538
10,060
Property and equipment, net
6,094
6,381
6,868
7,346
Operating leaseright-of-useassets
33,664
34,652
35,624
36,582
Restricted cash, net of current portion
2,139
2,139
2,139
2,139
Other assets
312
293
303
290
Total assets
1,073,880
435,792
398,690
210,136
Accounts payable
1,810
2,430
1,182
2,229
Accrued expenses and other current liabilities
15,546
9,068
17,759
13,113
Operating lease liabilities
2,943
2,832
2,738
3,102
Deferred revenue
-
-
0
0
Total current liabilities
20,299
14,330
21,679
18,444
Operating lease liabilities, net of current portion
29,049
29,956
30,832
31,661
Deferred revenue, net of current portion
-
-
0
0
Total liabilities
49,348
44,286
52,511
50,105
Common stock, 0.001 par value 400,000,000 and 200,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively168,380,091 and 135,940,454 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
168
144
136
112
Additionalpaid-incapital
1,729,004
1,040,143
948,971
724,201
Accumulated other comprehensive (loss) income
-633
-115
224
121
Accumulated deficit
-704,007
-648,666
-603,152
-564,403
Total stockholders' equity
1,024,532
391,506
346,179
160,031
Total liabilities and stockholders' equity
1,073,880
435,792
398,690
210,136
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$668,432K (372.35%↑ Y/Y)Cash and cashequivalents$345,558K (779.91%↑ Y/Y)Prepaid expenses andother current assets$17,681K (98.95%↑ Y/Y)Property, plant andequipment, gross$17,379K (-0.10%↓ Y/Y)Total current assets$1,031,671K (442.70%↑ Y/Y)Operatingleaseright-of-useassets$33,664K (-10.36%↓ Y/Y)Property and equipment,net$6,094K (-21.73%↓ Y/Y)Restricted cash, net ofcurrent portion$2,139K (0.00%↑ Y/Y)Other assets$312K (0.65%↑ Y/Y)Less accumulateddepreciation$11,285K (17.43%↑ Y/Y)Total assets$1,073,880K (351.42%↑ Y/Y)Total liabilities andstockholders' equity$1,073,880K (351.42%↑ Y/Y)Total stockholders'equity$1,024,532K (659.17%↑ Y/Y)Total liabilities$49,348K (-52.06%↓ Y/Y)Accumulated deficit-$704,007K (-21.32%↓ Y/Y)Accumulated othercomprehensive (loss) income-$633K (-773.40%↓ Y/Y)Additionalpaid-incapital$1,729,004K (141.81%↑ Y/Y)Operating leaseliabilities, net of current...$29,049K (-10.55%↓ Y/Y)Total currentliabilities$20,299K (-49.28%↓ Y/Y)Common stock, 0.001 parvalue 400,000,000 and...$168K (51.35%↑ Y/Y)Accrued expenses andother current...$15,546K (35.07%↑ Y/Y)Operating leaseliabilities$2,943K (16.14%↑ Y/Y)Accounts payable$1,810K (-30.57%↓ Y/Y)
TNGX_BIG

Tango Therapeutics, Inc. (TNGX)

TNGX_BIG

Tango Therapeutics, Inc. (TNGX)